Gu Dongxiao, Su Kaixiang, Zhao Huimin
School of Management, Hefei University of Technology, Hefei, Anhui, 230009, China; Key Laboratory of Process Optimization and Intelligent Decision-making of Ministry of Education, Hefei, Anhui, 230009, China.
School of Management, Hefei University of Technology, Hefei, Anhui, 230009, China.
Artif Intell Med. 2020 Jul;107:101858. doi: 10.1016/j.artmed.2020.101858. Epub 2020 Jun 5.
Significant progress has been achieved in recent years in the application of artificial intelligence (AI) for medical decision support. However, many AI-based systems often only provide a final prediction to the doctor without an explanation of its underlying decision-making process. In scenarios concerning deadly diseases, such as breast cancer, a doctor adopting an auxiliary prediction is taking big risks, as a bad decision can have very harmful consequences for the patient. We propose an auxiliary decision support system that combines ensemble learning with case-based reasoning to help doctors improve the accuracy of breast cancer recurrence prediction. The system provides a case-based interpretation of its prediction, which is easier for doctors to understand, helping them assess the reliability of the system's prediction and make their decisions accordingly. Our application and evaluation in a case study focusing on breast cancer recurrence prediction shows that the proposed system not only provides reasonably accurate predictions but is also well-received by oncologists.
近年来,人工智能(AI)在医学决策支持的应用方面取得了显著进展。然而,许多基于AI的系统通常仅向医生提供最终预测,而不解释其潜在的决策过程。在诸如乳腺癌等致命疾病的情况下,采用辅助预测的医生承担着巨大风险,因为错误的决策可能会对患者产生非常有害的后果。我们提出了一种辅助决策支持系统,该系统将集成学习与基于案例的推理相结合,以帮助医生提高乳腺癌复发预测的准确性。该系统为其预测提供基于案例的解释,医生更容易理解,有助于他们评估系统预测的可靠性并据此做出决策。我们在一项专注于乳腺癌复发预测的案例研究中的应用和评估表明,所提出的系统不仅提供了合理准确的预测,而且也受到肿瘤学家的好评。